What is the current computer aided drug discovery cadd market size?

The current computer aided drug discovery cadd market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the cadd market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the computer aided drug discovery market?

Key drivers include rising healthcare costs and the need for efficient drug discovery processes.

What challenges does the cadd market face?

Challenges include high development costs and the need for skilled professionals.

Which regions are expected to lead the computer aided drug discovery market?

North America and Europe are expected to lead due to strong healthcare infrastructure.

Who are the top companies in the cadd market?

Top companies include IBM, Microsoft, and Schrodinger, offering innovative solutions.

What future opportunities exist in the computer aided drug discovery market?

Future opportunities include increasing adoption in emerging markets and growing demand.

How will technology impact the cadd market future outlook?

Advances in AI and cloud computing will drive growth and innovation in the market.

What is the current regulatory landscape for the cadd market?

The regulatory landscape is evolving, with increasing focus on data security and compliance.

How will the computer aided drug discovery cadd market size change in the next 5 years?

The market size is expected to increase significantly, driven by growing demand and adoption.

computer aided drug discovery cadd Value Chain Analysis & Forecast Outlook 2033

computer aided drug discovery cadd by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 13.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 13.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

computer aided drug discovery cadd Market Overview

The computer aided drug discovery (CADD) market refers to the industry that leverages computational methods and algorithms to facilitate the discovery and development of new drugs. As the pharmaceutical industry continues to evolve, the CADD market size is anticipated to reach $4.8 billion by 2026, with a growth outlook that is poised to drive industry expansion. The market forecast suggests a compound annual growth rate (CAGR) of 12.2% from 2026 to 2033, driven by macro drivers such as increasing research and development investments, advancements in technology, and the need for more efficient and cost-effective drug discovery processes.

Loading chart…

The CADD market is being shaped by key forces such as technology shifts towards artificial intelligence and machine learning, regulatory requirements for more efficient and transparent drug discovery processes, and competitive intensity among pharmaceutical companies. The largest region in the CADD market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing investments in research and development and a growing demand for innovative drugs. As the industry continues to evolve, it is essential for C-suite executives, strategic planners, and business development teams to stay informed about the latest trends and developments in the CADD market.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.24 billion
Growth rate	CAGR of 13.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Light source type, interior design, application, end use, region
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Aaranya Biosciences Pvt. Ltd.; Albany Molecular Research Inc.; Charles River Laboratories International Inc.; ChemBio Discovery Inc.; Chemical Computing Group ULC; CompChem Solutions Ltd.; IBM https://www.ibm.com/; Kang Yusheng Information Technology Co. Ltd.; OpenEye Scientific Software Inc. https://www.eyesopen.com/; Pharmaron Beijing Co. Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The computer aided drug discovery cadd market is poised for significant growth, driven by a combination of technological advancements, regulatory requirements, and shifting demand patterns. This section provides an in-depth examination of the market dynamics influencing the computer aided drug discovery cadd market size and growth forecast.

Growth Drivers2 items

Increasing adoption of cloud-based platforms for drug discovery, enabling greater collaboration and data sharing among researchers and institutions

Advancements in artificial intelligence and machine learning algorithms, allowing for more accurate predictions and simulations in the drug discovery process

Restraints2 items

High initial investment costs associated with implementing computer aided drug discovery cadd systems, which can be a barrier for smaller research institutions and pharmaceutical companies

Concerns over data security and intellectual property protection, as sensitive information is shared and stored on cloud-based platforms

Opportunities2 items

Growing demand for personalized medicine and targeted therapies, driving the need for more efficient and effective drug discovery processes

Increasing focus on rare disease research, creating new opportunities for computer aided drug discovery cadd vendors to develop specialized platforms and tools

Challenges2 items

Integrating computer aided drug discovery cadd systems with existing research workflows and legacy systems, which can be time-consuming and resource-intensive

Addressing the skills gap in bioinformatics and computational biology, as researchers and institutions require specialized training to effectively utilize computer aided drug discovery cadd platforms

Market Segmentation

Loading chart…

The computer aided drug discovery cadd market can be segmented into several categories based on application. One of the primary segments is drug discovery, which involves the use of computer-aided design (CAD) software to identify and optimize lead compounds. This segment contributes significantly to the overall computer aided drug discovery cadd market size, as it enables pharmaceutical companies to streamline their discovery processes and reduce costs. The drug discovery segment is further divided into sub-segments, including target identification, lead generation, and lead optimization.

Another significant segment in the computer aided drug discovery cadd segmentation is drug development, which involves the use of CAD software to design and optimize drug candidates. This segment is critical to the overall market size, as it enables pharmaceutical companies to bring new drugs to market more quickly and efficiently. The drug development segment is further divided into sub-segments, including preclinical testing, clinical trials, and regulatory approval.

Regional Insights

Loading chart…

The computer aided drug discovery cadd market is witnessing significant growth globally, with distinct trends in various regions. The largest region, North America, accounts for approximately 40% of the market share, driven by key factors such as high adoption rates, favorable policies, and substantial investments in research and development. The Asia Pacific region is the fastest-growing, driven by increasing infrastructure, growing demographics, and maturing ecosystem.

Regional Drivers5 items

North America: high adoption rates, favorable policies, substantial investments

Europe: established infrastructure, skilled workforce, stringent regulations

Asia Pacific: increasing infrastructure, growing demographics, maturing ecosystem

Latin America: emerging markets, growing demand, limited infrastructure

Middle East & Africa: growing investments, limited adoption, developing infrastructure

The regional forecast indicates that the computer aided drug discovery cadd market growth will be influenced by factors such as government initiatives, technological advancements, and collaborations between industry players. As the market continues to evolve, it is essential to monitor the regional trends and market dynamics to capitalize on emerging opportunities.

Competitive Landscape

The computer aided drug discovery cadd market exhibits a moderately consolidated structure, driven by a mix of global players and local companies. Key competitive levers include pricing, product innovation, and regulatory approvals, which are critical in the computer aided drug discovery cadd competitive landscape. Global players focus on investing in research and development to enhance their product portfolios, while local companies concentrate on regional expansion and partnerships to strengthen their distribution networks.

Companies in this market employ various strategies, including mergers and acquisitions, partnerships, and product launches, to differentiate themselves and expand their customer base. However, they face challenges such as margin pressure, compliance costs, and commoditization, which can erode their competitive advantage. To stay competitive, companies must focus on innovative technologies, service models, and channel strength to maintain their market position.

Aaranya Biosciences Pvt. Ltd.: regional expansion

Albany Molecular Research Inc.: innovation pipeline

Charles River Laboratories International Inc.: vertical integration

ChemBio Discovery Inc.: premium pricing

Chemical Computing Group ULC: OEM tie-ups

CompChem Solutions Ltd.: local manufacturing

Key computer aided drug discovery cadd Companies10 items

Aaranya Biosciences Pvt. Ltd.

Albany Molecular Research Inc.

Charles River Laboratories International Inc.

ChemBio Discovery Inc.

Chemical Computing Group ULC

CompChem Solutions Ltd.

IBM https://www.ibm.com/

Kang Yusheng Information Technology Co. Ltd.

OpenEye Scientific Software Inc. https://www.eyesopen.com/

Pharmaron Beijing Co. Ltd.

Market Ecosystem

The computer aided drug discovery cadd ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development and deployment of specialized software and platforms that facilitate the discovery of new drugs. This complex ecosystem involves various participants, each playing a specific role in the value chain analysis.

Technology providers — develop cadd software and platforms

System integrators / EPCs — integrate cadd solutions with existing infrastructure

Distributors / channel partners — market and distribute cadd products

Service providers / after-sales — offer support and maintenance services

End users / buyers — utilize cadd solutions for drug discovery

Regulators/standards bodies — establish guidelines and standards for cadd adoption

Data/analytics providers — supply data and analytics for cadd applications

The flow of value within the computer aided drug discovery cadd ecosystem is influenced by control points, such as regulatory approvals and standards, which can create bottlenecks and impact adoption. Dependency risks, including input constraints and interoperability requirements, can also affect the ecosystem's functioning. Furthermore, switching costs and partnership requirements may vary across different regions, leading to regional differences in the ecosystem's structure and operation.

Recent Industry Insights

The computer aided drug discovery cadd industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between pharmaceutical companies and technology firms have accelerated the adoption of artificial intelligence and machine learning in drug discovery. Notable mergers and acquisitions have also taken place, with companies like Bayer and Merck expanding their capabilities in the CADD space.

Furthermore, several product and technology launches have been announced, including the introduction of new in silico modeling tools and cloud-based platforms for collaborative research. Regulatory changes, such as the FDA's guidance on the use of computer simulations in drug development, have also supported the growth of the CADD industry. As a result, funding rounds and expansions have increased, with investors showing keen interest in the computer aided drug discovery cadd industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the computer aided drug discovery cadd market outlook. The market attractiveness is high, driven by the increasing demand for efficient and cost-effective drug discovery processes. The competitive intensity is moderate, with key players investing heavily in research and development to stay ahead in the market.

The long-term outlook for the computer aided drug discovery cadd market is promising, with the innovation landscape expected to evolve significantly in the coming years. The demand-supply balance is currently skewed, with demand outpacing supply. Key risk factors include regulatory challenges and the need for high-quality data. Overall, the market is poised for growth, driven by the need for innovative and efficient drug discovery solutions.

11 items

1. Executive Summary

2. computer aided drug discovery cadd Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global computer aided drug discovery cadd Market Outlook & Forecast (2021-2033) Value (USD Million)

7. Global computer aided drug discovery cadd Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global computer aided drug discovery cadd Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

8. Global computer aided drug discovery cadd Market Competition by Key Manufacturers

8.1. Global computer aided drug discovery cadd Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global computer aided drug discovery cadd: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Aaranya Biosciences Pvt. Ltd.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Albany Molecular Research Inc.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Charles River Laboratories International Inc.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. ChemBio Discovery Inc.

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Chemical Computing Group ULC

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. CompChem Solutions Ltd.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. IBM https://www.ibm.com/

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Kang Yusheng Information Technology Co. Ltd.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. OpenEye Scientific Software Inc. https://www.eyesopen.com/

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Pharmaron Beijing Co. Ltd.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

16 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global computer aided drug discovery cadd Market

Figure 4: Global computer aided drug discovery cadd Market: Drivers

Figure 5: Global computer aided drug discovery cadd Market: Challenges

Figure 6: Global computer aided drug discovery cadd Market: Trends

Figure 7: Global computer aided drug discovery cadd Market: Opportunity

Figure 8: Global computer aided drug discovery cadd Market: Restraint

Figure 9: Global computer aided drug discovery cadd Market: Porter's Five Forces

Figure 10: Global computer aided drug discovery cadd Market Value (USD Million) By Region

Figure 11: Global computer aided drug discovery cadd Market Share (%) By: Regions (2024)

Figure 12: Top 5 Manufacturers

Figure 13: Top 3 Manufacturers

Figure 14: Global computer aided drug discovery cadd Market Value (USD Million) By Region

Figure 15: Global computer aided drug discovery cadd Market Share (%) By: Regions (2032)

Figure 16: Data Triangulation

List of Tables

43 items

Table 1: Market Segmentation Analysis

Table 2: Global computer aided drug discovery cadd Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 3: Global computer aided drug discovery cadd Market Value (USD Million) By Region

Table 4: Global computer aided drug discovery cadd Market Share (%) By Region

Table 5: North America Market Value (USD Million) (2020-2024) By Country

Table 6: Europe Market Value (USD Million) (2020-2024) By Country

Table 7: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 8: South America Market Value (USD Million) (2020-2024) By Country

Table 9: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 10: Global computer aided drug discovery cadd Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 11: Global computer aided drug discovery cadd Market: Profiled Players Head Office And Area Served

Table 12: Key Players Global computer aided drug discovery cadd Market:

Table 13: Mergers & Acquisitions, Expansion Plans

Table 14: Aaranya Biosciences Pvt. Ltd. Basic Information And Sales Area

Table 15: Aaranya Biosciences Pvt. Ltd.. Products Portfolio

Table 16: Albany Molecular Research Inc. Basic Information And Sales Area

Table 17: Albany Molecular Research Inc.. Products Portfolio

Table 18: Charles River Laboratories International Inc. Basic Information And Sales Area

Table 19: Charles River Laboratories International Inc.. Products Portfolio

Table 20: ChemBio Discovery Inc. Basic Information And Sales Area

Table 21: ChemBio Discovery Inc.. Products Portfolio

Table 22: Chemical Computing Group ULC Basic Information And Sales Area

Table 23: Chemical Computing Group ULC. Products Portfolio

Table 24: CompChem Solutions Ltd. Basic Information And Sales Area

Table 25: CompChem Solutions Ltd.. Products Portfolio

Table 26: IBM https://www.ibm.com/ Basic Information And Sales Area

Table 27: IBM https://www.ibm.com/. Products Portfolio

Table 28: Kang Yusheng Information Technology Co. Ltd. Basic Information And Sales Area

Table 29: Kang Yusheng Information Technology Co. Ltd.. Products Portfolio

Table 30: OpenEye Scientific Software Inc. https://www.eyesopen.com/ Basic Information And Sales Area

Table 31: OpenEye Scientific Software Inc. https://www.eyesopen.com/. Products Portfolio

Table 32: Pharmaron Beijing Co. Ltd. Basic Information And Sales Area

Table 33: Pharmaron Beijing Co. Ltd.. Products Portfolio

Table 34: Global computer aided drug discovery cadd Market Value (USD Million) By Region

Table 35: Global computer aided drug discovery cadd Market Share (%) By Region (2025-2032)

Table 36: North America Market Value (USD Million) (2025-2032) By Country

Table 37: Europe Market Value (USD Million) (2025-2032) By Country

Table 38: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 39: South America Market Value (USD Million) (2025-2032) By Country

Table 40: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 41: Research Programs/Design For This Report

Table 42: Key Data Information From Secondary Sources

Table 43: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

computer aided drug discovery cadd Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.24 billion
Growth rate	CAGR of 13.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Light source type, interior design, application, end use, region
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Aaranya Biosciences Pvt. Ltd.; Albany Molecular Research Inc.; Charles River Laboratories International Inc.; ChemBio Discovery Inc.; Chemical Computing Group ULC; CompChem Solutions Ltd.; IBM https://www.ibm.com/; Kang Yusheng Information Technology Co. Ltd.; OpenEye Scientific Software Inc. https://www.eyesopen.com/; Pharmaron Beijing Co. Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Increasing adoption of cloud-based platforms for drug discovery, enabling greater collaboration and data sharing among researchers and institutions

Advancements in artificial intelligence and machine learning algorithms, allowing for more accurate predictions and simulations in the drug discovery process

Restraints2 items

High initial investment costs associated with implementing computer aided drug discovery cadd systems, which can be a barrier for smaller research institutions and pharmaceutical companies

Concerns over data security and intellectual property protection, as sensitive information is shared and stored on cloud-based platforms

Opportunities2 items

Growing demand for personalized medicine and targeted therapies, driving the need for more efficient and effective drug discovery processes

Increasing focus on rare disease research, creating new opportunities for computer aided drug discovery cadd vendors to develop specialized platforms and tools

Challenges2 items

Integrating computer aided drug discovery cadd systems with existing research workflows and legacy systems, which can be time-consuming and resource-intensive

Market Segmentation

Loading chart…

Regional Insights

Loading chart…

Regional Drivers5 items

North America: high adoption rates, favorable policies, substantial investments

Europe: established infrastructure, skilled workforce, stringent regulations

Asia Pacific: increasing infrastructure, growing demographics, maturing ecosystem

Latin America: emerging markets, growing demand, limited infrastructure

Middle East & Africa: growing investments, limited adoption, developing infrastructure

Competitive Landscape

Aaranya Biosciences Pvt. Ltd.: regional expansion

Albany Molecular Research Inc.: innovation pipeline

Charles River Laboratories International Inc.: vertical integration

ChemBio Discovery Inc.: premium pricing

Chemical Computing Group ULC: OEM tie-ups

CompChem Solutions Ltd.: local manufacturing

Key computer aided drug discovery cadd Companies10 items

Aaranya Biosciences Pvt. Ltd.

Albany Molecular Research Inc.

Charles River Laboratories International Inc.

ChemBio Discovery Inc.

Chemical Computing Group ULC

CompChem Solutions Ltd.

IBM https://www.ibm.com/

Kang Yusheng Information Technology Co. Ltd.

OpenEye Scientific Software Inc. https://www.eyesopen.com/

Pharmaron Beijing Co. Ltd.

Market Ecosystem

Technology providers — develop cadd software and platforms

System integrators / EPCs — integrate cadd solutions with existing infrastructure

Distributors / channel partners — market and distribute cadd products

Service providers / after-sales — offer support and maintenance services

End users / buyers — utilize cadd solutions for drug discovery

Regulators/standards bodies — establish guidelines and standards for cadd adoption

Data/analytics providers — supply data and analytics for cadd applications

Recent Industry Insights

Analyst Overview

Table of Contents